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HEALTH AND HUMAN RIGHTS
In South Africa, the euphoria of thepeaceful transition from apartheid
to democracy has been dulled by the
devastation of HIV/AIDS. The
epidemic has had a disproportionate
effect on poor, previously disenfran-
chised groups, in which the apartheid
migrant labour system had destroyed
family life and created conjugal
instability. South Africa is now in the
midst of a maturing epidemic, and
AIDS dominates almost all aspects of
medical care. HIV-1 prevalence
reached 24·5% in pregnant women
attending public health services in
2002.1
Highly active antiretroviral therapy
(HAART) symbolises hope for many
communities. But access to these life-
saving drugs was severely restricted
until the 2000 International AIDS
Conference in Durban, South Africa.
This defining moment2 in global
solidarity and advocacy for treatment
access changed the discourse on AIDS
treatment in poor countries from “if”
to “when”. The change was largely
due to rapid price reductions and
funding made available by, among
others, the Global Fund to fight
AIDS, Tuberculosis, and Malaria.
Although there have been many
events to celebrate in postapartheid
South Africa, the government’s
response to the AIDS epidemic was,
until very recently, not one. 
Before 1994, the apartheid
government’s approach to dealing
with AIDS was insufficient and
lacked credibility. The Mandela
government set about redressing this
in 1994 by establishing AIDS as one
of the 23 presidential lead projects
and one of the 12 reconstruction and
development programmes. This
initial period of hope was, however,
short lived. The biggest setback came
when President Mbeki (who took
office in 1999) expressed doubt
about whether HIV causes AIDS.
Mbeki also questioned the safety and
efficacy of antiretrovirals. Subse-
quently, a presidential AIDS panel
was created with equal numbers of
AIDS denialists and orthodox AIDS
scientists, but it is yet to report
recommendations.
In 2001, advocacy groups
challenged the government’s decision
not to provide two-dose nevirapine
treatment to reduce the risk of
mother-to-child transmission of 
HIV-1. The Constitutional Court’s
ruling against the government was a
landmark, and it showed that the
country’s constitution could hold the
government accountable for its
actions (or in this case inaction). 
Under increasing pressure to
address treatment access, the
government adopted the national
treatment plan, which recognised that
by mid-2003 about half a million
South Africans were in need of anti-
retroviral treatment. The plan estab-
lished a commitment to measure
CD4 counts in about 200000 people
with HIV infection; starting 53000 on
HAART by the end of March, 2004,
and another 180000 by the end of
March, 2005. The Department of
Health aimed for at least one service
point in every health district within 1
year, and one in every municipality
within 5 years.
The Western Cape Province was
the first to provide AIDS treatment
free of charge in selected govern-
ment hospitals, building on experi-
ence from the Médecin sans
Frontières treatment project in
Khayelitsha.3
Efforts to overcome operational
constraints to national coverage of
AIDS treatment include: urgent
procurement of medicines; speedy
accreditation of treatment sites;
resource allocation to underdeveloped
sites to build capacity for site accred-
itation and treatment roll out; clear,
accurate, and appropriate  advice on
testing, treatment, nutrition, and
prevention; and training and support
of health-care personnel.
If the targets set out in the national
AIDS treatment plan are to be met,
South Africa will have to create the
largest AIDS treatment programme in
the world—a feat that needs the
assistance from all sectors of South
African society as well as international
support to achieve success. 
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Milestones in access to treatment for HIV in South Africa
April, 2000:Médecins Sans Frontières and TAC start HAART provision at three
government primary health care clinics in Khayalitsha
July, 2000: 13th International AIDS Conference march for treatment access
March, 2001: Pharmaceutical industry withdraw court case against the state 
on parallel importation and generic drug procurement.
April, 2002: Global Fund donate US$72 million to KwaZulu-Natal. Constitutional
court rejects government appeal of the Pretoria High Court decision and orders
government to provide drugs for the prevention of mother-to-child transmission of
HIV at all public health-care facilities in South Africa.
November, 2002: Nelson Mandela Foundation sponsors workshop in Durban on
treatment access 
August, 2003: First South African AIDS conference, Durban; government support
national treatment plan for AIDS treatment options in the public sector.
October, 2003: Competition Commission rule that GlaxoSmithKline and
Boehringer Ingelheim abused their dominant positions in antiretrovirals market
January, 2004: Western Cape government expands HAART roll-out, and by the
end of March, 2004, 2000 patients start treatment through an emergency drug
procurement mechanism.
February, 2004: Government accepts money from Global Fund
March 2004: Boehringer Ingelheim threatens to disinvest from South Africa
because of dissatisfaction about draft medicine pricing regulations of the
Department of Health. TAC threatens to legal action against the government if it
fails to implement HAART programme.
April 1, 2004: Announcement of AIDS treatment roll-out in 27 pilot sites in four
of nine provinces 
April 15, 2004: African National Congress (ANC) wins third democratic election
in South Africa. Whether enthusiasm for HIV treatment programmes generated
during election campaign will be sustained remains to be seen. 
